Alx Oncology Holdings (ALXO) Profit After Tax Growth (1y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 65.80% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 17.05% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -290.15% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 59.59% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -129.68% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -10.08% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,228.66% |
| 10 | Alx Oncology Holdings | 189.80 Mn | 49.48 Mn | - | 41.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 41.71% |
| Dec 31, 2025 | 21.65% |
| Sep 30, 2025 | 27.89% |
| Jun 30, 2025 | 34.14% |
| Mar 31, 2025 | 13.57% |
| Dec 31, 2024 | 35.87% |
| Sep 30, 2024 | 39.78% |
| Jun 30, 2024 | -15.34% |
| Mar 31, 2024 | -17.88% |
| Dec 31, 2023 | -48.07% |
| Sep 30, 2023 | -44.37% |
| Jun 30, 2023 | -3.76% |
| Mar 31, 2023 | -23.03% |
| Dec 31, 2022 | -7.99% |
| Sep 30, 2022 | -43.78% |
| Jun 30, 2022 | -102.29% |
| Mar 31, 2022 | -72.95% |
| Dec 31, 2021 | -51.48% |
| Sep 30, 2021 | -141.29% |
| Jun 30, 2021 | -43.62% |
| Mar 31, 2021 | -160.08% |
| Dec 31, 2020 | -141.81% |
| Sep 30, 2020 | -234.46% |
| Jun 30, 2020 | -169.98% |